Review article: monitoring of immunomodulators in inflammatory bowel disease.
about
Thiopurine monitoring in children with inflammatory bowel disease: a systematic reviewModel-based contextualization of in vitro toxicity data quantitatively predicts in vivo drug response in patients.Cyclosporine for severe ulcerative colitis.Prophylaxis against Pneumocystis pneumonia in patients with inflammatory bowel disease: toward a standard of care.Cost-Effectiveness of Infliximab for the Treatment of Acute Exacerbations of Ulcerative Colitis in the Netherlands.Are patients with intermediate TPMT activity at increased risk of myelosuppression when taking thiopurine medications?An evidence-based systematic review on medical therapies for inflammatory bowel disease.The effective therapy of cyclosporine A with drug delivery system in experimental colitis.Common misconceptions about 5-aminosalicylates and thiopurines in inflammatory bowel disease.Thiopurine maintenance therapy for ulcerative colitis: the clinical significance of monitoring 6-thioguanine nucleotide.A validated HPLC method for the monitoring of thiopurine metabolites in whole blood in paediatric patients with inflammatory bowel disease.Thiopurine methyltransferase (TPMT) activity and adverse effects of azathioprine in inflammatory bowel disease: long-term follow-up study of 394 patients.Glutathione-S-transferase genotypes and the adverse effects of azathioprine in young patients with inflammatory bowel disease.Colon-targeted delivery of cyclosporine A using dual-functional Eudragit® FS30D/PLGA nanoparticles ameliorates murine experimental colitis.
P2860
Q26859122-6EF02615-4FD5-4235-A11D-678AF0B78079Q30838395-E5570B44-5CB6-40E0-8852-F7AC3F58AADEQ36348371-BC2CD582-331C-44C4-ACF1-166F67697817Q36948496-0C374212-950E-4252-8A1D-E13157E17223Q37414620-FDEF9DF3-2DD0-493B-8DA1-8D5E7CAC2056Q37688050-216D09F9-1B87-4FB2-BA35-45D0DEA19728Q37862584-53A74CDF-6353-44A9-A3BE-A4DC3CC1F00CQ39661783-0A807C89-CB0A-4E81-8D68-21C15D80E648Q42877648-AECE2A1F-9624-40CF-B704-894E0E1476F9Q43202350-4FA2F141-72D4-47E0-A0E8-6B429F45DF86Q50509073-69B61D6D-49E2-479C-9B95-082A23F09D84Q50719037-5F17E880-74C5-4980-9FA3-4168FB84F2B6Q54563956-7343A40D-823C-4757-90EF-B3BB1CCD736AQ55113137-BA1CE441-E94B-45BE-A26C-7F731005383B
P2860
Review article: monitoring of immunomodulators in inflammatory bowel disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Review article: monitoring of immunomodulators in inflammatory bowel disease.
@ast
Review article: monitoring of immunomodulators in inflammatory bowel disease.
@en
type
label
Review article: monitoring of immunomodulators in inflammatory bowel disease.
@ast
Review article: monitoring of immunomodulators in inflammatory bowel disease.
@en
prefLabel
Review article: monitoring of immunomodulators in inflammatory bowel disease.
@ast
Review article: monitoring of immunomodulators in inflammatory bowel disease.
@en
P2860
P1476
Review article: monitoring of immunomodulators in inflammatory bowel disease.
@en
P2093
Lichtenstein GR
P2860
P304
P356
10.1111/J.1365-2036.2005.02343.X
P407
P577
2005-02-01T00:00:00Z